ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
ACAD
38.17
+0.26
+0.69%
AEMD
7.05
-0.1
-1.40%
APRI
1.35
+0.12
+9.76%
ARNA
2.71
+0.06
+2.26%
ATEC
0.54
-0.03
-5.26%
CNAT
4.05
+0.37
+10.05%
CRXM
0.37
-0.02
-5.13%
CYTX
0.315
+0.016
+5.246%
DXCM
94.19
+0.45
+0.48%
GNMK
10.02
+0.59
+6.26%
HALO
18.41
+0.37
+2.05%
ILMN
201.7
-0.24
-0.12%
INNV
0.148
+0.003
+2.069%
INO
7.73
+0.75
+10.74%
ISCO
3.98
+0.33
+9.04%
ISIS
51.54
-0.02
-0.04%
LGND
95.04
+0.79
+0.84%
LPTN
0.225
+0.015
+7.092%
MBVX
1.685
-0.005
-0.296%
MEIP
1.73
+0.04
+2.37%
MNOV
2.94
-0.03
-1.01%
MRTX
26.66
+1.17
+4.59%
MSTX
0.47
+0.02
+3.96%
NBIX
46.67
+0.41
+0.89%
NUVA
53.75
+1
+1.90%
ONCS
5.2
+0.02
+0.48%
ONVO
2.54
+0.04
+1.60%
OREX
2.89
+0.13
+4.71%
OTIC
23.5
+0.12
+0.51%
QDEL
20.45
-0.25
-1.21%
RCPT
231.96
0.00
0.00%
RGLS
8.27
+0.79
+10.56%
RMD
52.47
+0.82
+1.59%
SCIE
0.015
+0.001
+3.5714%
SPHS
0.89
+0.03
+3.49%
SRNE
13.65
+0.33
+2.48%
TROV
6.33
+0.55
+9.52%
VICL
0.59
+0.03
+5.32%
VOLC
18
0.00
0.00%
ZGNX
18.41
+1.35
+7.91%
Home » Hugo Villar, Ph.D., MBA-Bio

Hugo Villar, Ph.D., MBA-Bio

Hugo O. Villar Ph.D., MBA is director for Science and Technology programs at UC San Diego Extension. He is also President of Altoris, Inc. a San Diego based specializing in information management for the biotech and pharmaceutical industries and providing consulting on discovery technologies. He was Vice President for Chemoproteomics at Triad Therapeutics and Vice President of Discovery Technologies at Telik, Inc. His work resulted in over 80 publications and 18 patents on the development of technologies for drug discovery. He has a Ph.D. in Chemistry and an MBA with a concentration in Pharmaceuticals and Helathcare.